A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...